Antagonism of calmodulin-stimulated adenylate cyclase by trifluoperazine, calmidazolium and W-7 in rat cerebellar membranes.

Ca++-calmodulin (CaM)-dependent stimulation of adenylate cyclase in rat cerebellar plasma membranes was demonstrated by removal of endogenous Ca++ and CaM and addition of exogenous Ca++ and CaM to the membranes. This CaM-dependent adenylate cyclase activity could be inhibited by calmidazolium and trifluoperazine in an apparently competitive manner, whereas the inhibition produced by W-7 was not competitive. The potency of the antagonists was strictly dependent upon the concentration of exogenous CaM present in the assay. Preincubation of membranes with exogenous CaM, followed by addition of anti-CaM agents, greatly reduced the inhibition of CaM-dependent adenylate cyclase activity. The potency of the anti-CaM agents was further decreased in membranes that had not been depleted of endogenous Ca++ and CaM (native membranes). The results suggest that optimal inhibition of CaM-dependent adenylate cyclase activity occurs upon simultaneous addition of exogenous CaM and anti-CaM agents to membranes depleted of endogenous Ca++ and CaM. Association of CaM with the catalytic unit of adenylate cyclase before introduction of CaM antagonists results in a CaM-C complex that is relatively refractory to inhibition by these anti-CaM agents. This CaM-catalytic unit complex probably exists in native membranes, rendering the antagonism of adenylate cyclase activity supported by endogenous Ca++-CaM essentially insensitive to low concentrations of CaM antagonists.

• Publication year

  1987

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1987-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0022-5347(25)00282-4PMID 3106618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.

  1986cited by this paper
• Biphasic Ca2+ response of adenylate cyclase. The role of calmodulin in its activation by Ca2+ ions.

  1986cited by this paper
• Purification of the calmodulin-sensitive adenylate cyclase from bovine cerebral cortex.

  1985cited by this paper
• Inositol trisphosphate, a novel second messenger in cellular signal transduction

  1984cited by this paper
• Role of Calmodulin in the Effect of Guanyl Nucleotides on Rat Hippocampal Adenylate Cyclase: Involvement of Adenosine and Opiates

  1983cited by this paper
• Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships.

  1982cited by this paper
• Activation and attenuation of adenylate cyclase. The role of GTP-binding proteins as macromolecular messengers in receptor--cyclase coupling.

  1981cited by this paper
• R 24571: a new powerful inhibitor of red blood cell Ca++-transport ATPase and of calmodulin-regulated functions.

  1981cited by this paper
• Calmodulin pharmacology.

  1981cited by this paper
• Calmodulin activates the isolated catalytic unit of brain adenylate cyclase.

  1981cited by this paper
• Effect of calmodulin on dopamine-sensitive adenylate cyclase activity in rat striatal membranes.

  1981cited by this paper
• Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase.

  1980cited by this paper
• Calcium-induced exposure of a hydrophobic surface on calmodulin.

  1980cited by this paper
• The role of hormone receptors and GTP-regulatory proteins in membrane transduction

  1980cited by this paper
• Hydrophobic regions function in calmodulin-enzyme(s) interactions.

  1980cited by this paper
• Calmodulin.

  1980cited by this paper
• Calmodulin—an intracellular calcium receptor

  1980cited by this paper
• Calmodulin plays a pivotal role in cellular regulation.

  1980cited by this paper
• Calmodulin activation of red blood cell (Ca2+ + Mg2+)-ATPase and its antagonism by phenothiazines.

  1980cited by this paper
• Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.

  1979cited by this paper
• Calmodulin activation of adenylate cyclase in pancreatic islets.

  1979cited by this paper
• Resolution of adenylate cyclase sensitive and insensitive to Ca2+ and calcium-dependent regulatory protein (CDR) by CDR-sepharose affinity chromatography.

  1979cited by this paper
• Ca2+-dependent protein phosphorylation system in membranes from various tissues, and its activation by "calcium-dependent regulator".

  1978cited by this paper
• Stimulation of brain membrane protein phosphorylation by calcium and an endogenous heat-stable protein

  1978cited by this paper
• Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins.

  1978cited by this paper
• Calcium-dependent adenylate cyclase from rat cerebral cortex. Reversible activation by sodium fluoride.

  1977cited by this paper
• Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.

  1977cited by this paper
• Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.

  1976cited by this paper
• Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein.

  1976cited by this paper
• Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase.

  1975cited by this paper
• Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase.

  1975cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper
• Mechanism of activation of a cyclic adenosine 3':5'-monophosphate phosphodiesterase from bovine heart by calcium ions. Identification of the protein activator as a Ca2+ binding protein.

  1973cited by this paper
• Purification and properties of the protein activator of bovine heart cyclic adenosine 3',5'-monophosphate phosphodiesterase.

  1973cited by this paper
• The membrane actions of anesthetics and tranquilizers.

  1972cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotype

  2022cites this paper
• Novel Treatments for Chronic Pain: Moving Beyond Opioids.

  2021cites this paper
• Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin-Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin.

  2017cites this paper
• Membranous adenylyl cyclase 1 activation is regulated by oxidation of N- and C-terminal methionine residues in calmodulin.

  2015cites this paper
• Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor

  2015influential citation
• Functional characteristics of calcium-sensitive adenylyl cyclase of the infusorian Tetrahymena pyriformis

  2010cites this paper
• Structural basis for inhibition of mammalian adenylyl cyclase by calcium.

  2009cites this paper
• Regulatory calcium effect on adenylyl cyclase functional activity in the infusorian Dileptis anser

  2007cites this paper
• Capacitative and 1-Oleyl-2-acetyl-sn-glycerol-Activated Ca2+ Entry Distinguished Using Adenylyl Cyclase Type 8

  2006cites this paper
• The Cytosolic Domains of Ca2+-sensitive Adenylyl Cyclases Dictate Their Targeting to Plasma Membrane Lipid Rafts*

  2005cites this paper
• Sustained Entry of Ca2+ Is Required to Activate Ca2+-Calmodulin-dependent Phosphodiesterase 1A*

  2004cites this paper
• Fendiline and calmidazolium enhance the release of endothelium-derived relaxant factor and of prostacyclin from cultured endothelial cells

  2004cites this paper
• Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells.

  2004cites this paper
• SQ22536 and W-7 inhibit forskolin-induced cAMP elevation but not relaxation in newborn ovine pulmonary veins.

  2001cites this paper
• Effect of calmidazolium analogs on calcium influx in HL-60 cells.

  2000cites this paper
• Inhibition by Calcium of Mammalian Adenylyl Cyclases*

  1999cites this paper
• Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.

  1999cites this paper
• Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.

  1999cites this paper
• Overshooting cytosolic Ca2+ signals evoked by capacitative Ca2+ entry result from delayed stimulation of a plasma membrane Ca2+ pump.

  1999cites this paper
• Dependence of the Ca2+-inhibitable Adenylyl Cyclase of C6–2B Glioma Cells on Capacitative Ca2+ Entry*

  1998cites this paper
• Construction of a Full-length Ca2+-sensitive Adenylyl Cyclase/Aequorin Chimera*

  1997cites this paper
• Acute Dystonic Reaction to Methotrimeprazine in Hypoparathyroidism

  1996cites this paper
• Adenylate cyclase activity from Hirudo medicinalis segmental ganglia: modulation by calcium and calmodulin.

  1995cites this paper
• [5] Regulation of Ca2+sensitive adenylyl cyclases by calcium ion in vitro and in vivo

  1994cites this paper
• Regulation of Ca(2+)-sensitive adenylyl cyclases by calcium ion in vitro and in vivo.

  1994cites this paper
• Calmodulin in neurotransmitter and hormone action.

  1993cites this paper
• Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase.

  1993cites this paper
• The calmodulin antagonist calmidazolium stimulates release of nitric oxide in neuroblastoma N1E-115 cells.

  1993cites this paper
• Calmodulin antagonists inhibit endothelium‐dependent hyperpolarization in the canine coronary artery

  1992cites this paper
• The effects of Ca2+ and calmodulin on adenylyl cyclase activity in plasma membranes derived from neural and non-neural cells.

  1992cites this paper
• Carbachol stimulates adenylate cyclase and phospholipase C and muscle contraction-relaxation in a reciprocal manner in dog iris sphincter smooth muscle.

  1992cites this paper
• Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions.

  1991cites this paper
• Evaluation of the role of GTP hydrolysis in the interaction between Mg2+ and GTP in regulating agonist binding to the adenosine A1 receptor.

  1991cites this paper
• Bradykinin stimulates Ca2+ mobilization in NCB-20 cells leading to direct inhibition of adenylylcyclase. A novel mechanism for inhibition of cAMP production.

  1991cites this paper
• Calcium‐dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin

  1990cites this paper
• Potent and cooperative feedback inhibition of adenylate cyclase activity by calcium in pituitary-derived GH3 cells.

  1990cites this paper
• Differential expression of low molecular weight form of Gs-alpha in neostriatum and cerebellum: correlation with expression of calmodulin-independent adenylyl cyclase.

  1990cites this paper
• Neuromodulation: associative and nonlinear adaptation.

  1990cites this paper
• Blockade by lipoxygenase inhibitors of Ca2+-dependent insulin secretion from permeabilized rat islets. A molecular mechanism distinct from that of alpha 2-adrenergic agonists.

  1989cites this paper
• Exogenous Arachidonic Acid Promotes Insulin Release From Intact or Permeabilized Rat Islets by Dual Mechanisms: Putative Activation of Ca2+ Mobilization and Protein Kinase C

  1988cites this paper
• Calmodulin plays a dominant role in determining neurotransmitter regulation of neuronal adenylate cyclase

  1988cites this paper
• Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.

  1987cites this paper